Veröffentlichungen

Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer

Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.

Order by:

[o.141] WAO Guideline for the management of hereditary angioedema (0)
[o.167] Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe (0)
[o.173] Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study (0)
[o.179] Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema (0)
[o.359] Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey (0)
[o.302] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study (4)
[o.340] Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey (2)
[o.308] The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update (0)
[o.337] Guideline: Hereditary angioedema due to C1 inhibitor deficiency. S1-Guideline of the German Society for Angioedema (DGA), German Society for Internal Medicine (DGIM), German Society for Otorhinolaryngology (DGHNO), German Society for Allergology and Clinical Immunology (DGAKI), German Society for Child and Adolescent Medicine (DGKJ), German Dermatological Society (DDG), German Society for Pediatric Allergology and Environmental Medicine (GPA), German Association of ENT Surgeons (BVHNO) and the German HAE Patient Association (HAE-SHG) (0)
[o.309] The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update (4)
[o.326] Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPuS-2 study (0)
[o.328] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the icatibant outcome survey (3)
[r.128] Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema (5)
[r.122] Hereditary angioedema with normal C1 inhibitor: Update on evaluation and treatment (0)
[r.037] Treatment of acute attacks of hereditary angioedema (HAE) with the bradykinin B2 receptor antagonist icatibant (0)
[r.045] Hereditary angioedema: an update on available therapeutic options (0)
[r.051] Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives (4)
[o.205] Hereditary angioedema: Molecular and clinicaldifferences among European populations (0)
[o.289] Genetic determinants of C1 inhibitor deficiency angioedema age of onset (0)
[o.216] Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies (0)

(Last update: 07.2025)

Number of original publications in peer-reviewed journals:	650
Number of reviews in peer-reviewed journals:	229
Number of publications (original work and reviews) in peer-reviewed journals:	879
Cumulative IF for original publications in peer-reviewed journals:	4648.29
Cumulative IF for reviews in peer-reviewed journals:	1689.22
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:	6761.91
Total number of citations: 45.522, h-index: 109 (Web of Science Juli 2025)	45522

Download-Information

Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.